Athleisure Market Size Worth $517.5 Billion By 2025

The global athleisure market size is expected to reach USD 517.5 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.1% over the forest period. Increasing adoption of fashionable active wear in corporate houses and work places is expected to be a key driver. In addition, extensive brand campaigns by apparel manufacturers through the inclusion of various media and sports celebrities have changed the perception of active wear as a fashionable wear among millennial and young customers across the globe.

Premium athleisure was the largest product segment with a market share of more than 65.0% in 2018. Major manufacturers including Adidas AG;Lululemon Athletica, Inc.; Nike, Inc.; PUMA SE; and Under Armour, Inc. are collaborating with the celebrities and launching new products in order to gain maximum customers.

For instance, in March 2016, Julianne Hough signed an agreement with MPG Sport USA for promoting athleisure collection. The company collaborated with the actress for influencing the customers with a fitness freak actress. These initiatives are expected to increase the product’s visibility among buyers over the next few years.

Asia Pacific is expected to be the fastest growing region at a CAGR of 8.8% from 2019 to 2025. Over the past few years, the industry participants have adopted marketing strategies including innovative product launches, celebrity endorsements, increasing exclusive stores, and focus on e-commerce in order to cater to the increasing demand for technological advanced products in the developing countries including China and India.

For instance, in April 2018, Adidas AG announced to close their brand stores and focus on the development of e-commerce. The company has already closed around 220 stores across the globe in 2017 and is aiming to increase the revenue generated from e-commerce. These trends are expected to boost the market growth over the forecast period.

Key players include Lululemon Athletica, Inc.; Adidas AG; Nike, Inc.; PUMA SE; Under Armour, Inc.; AJIO Company; H&M; HUMAN PERFORMANCE ENGINEERING; EYSOM, LLC; and Esprit Retail B.V. & Co. KG. Product innovation is expected to remain a critical success factor among the manufacturing firms over the next few years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/athleisure-market

Further key findings from the report suggest:

Asia Pacific for athleisure market is expected to register the fastest CAGR of 8.8% from 2019 to 2025
North America was the largest market, with a share of more than 30.0% in 2018
Premium athleisure was the largest product segment, with a share of more than 65.0% in 2018
Online is expected to be the fastest growing segment at a CAGR of 8.5% from 2019 to 2025.

Men’s Underwear Market Worth $42.22 Billion By 2025

The global men’s underwear market size is expected to reach USD 42.22 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 5.3% during the forecast period. Increasing awareness about health, best fit and personal hygiene, and rise in millennial population, are expected to drive the growth. Increasing availability of a wide range of products in multiple designs suitable for various purposes such as sports, regular wear, and functional wear among others is projected to further fuel the demand.

Improving fashion trends, increasing disposable income, and changing consumer lifestyle and preferences are expected to boost the market growth. Increasing concerns regarding the fabric used for manufacturing underwear is one of the major factor driving the market. Availability of a wide variety of fabrics such as cotton, polyester, nylon, rayon, silk, and cotton blends further drive the product demand. Underwear manufactures are focusing on intimate product designs and patterns such as thongs, C-string, tanga, and jockstraps among others, which is projected to further fuel the product demand. Millennials are more receptive to new and different products. Demand for new and innovative products in terms of color, fabric, print, and style among others is high among millennials, which in turn is creating opportunity for the manufactures in the market.

Companies focus on R&D to make the products suitable for all shapes and sizes. Innovation in advance tailoring along with new fabric modal, viscose or merino wool, helps in reducing moisture and regulate temperature is driving the competitiveness in the market. For Instance, Saxx offer 3D hammock shaped pouch that prevent skin-against-skin friction with the help of mesh panels which features no exposed stitching for chafe free comfort. Also, Under Three-D fit range they have created a 3D shaping around glutes, thighs, quads and hamstrings by using nine panels of fabric to make consumers fit, feel and functional.

By type, the men’s underwear market is segmented into briefs, boxer brief, trunks, boxers, and others. Boxer brief is estimated to hold the largest market share of approximately 33.0% owing to the factors such as sleek fit, better support, and comfort offered by the product. Boxer brief are designed to imitate tapered boxers with a snug fit and they remain comfortable like briefs. They are available with numerous pouch options, for instance the contour pouch by Calvin Kelvin.

Trunks is estimated to register the fastest CAGR of 5.7% from 2019 to 2025. Trunks are gaining popularity among millennials and Generation X as they are more versatile and suitable for everyday wear including dressing up occasions and for sportswear. Trunks are lean short than boxer brief which allow the legs and thighs to look muscular and slimmer, which drives their popularity among younger generation.

By Fabric, the market is segmented into cotton, polyester, modal, nylon, and others. Cotton fabric underwear held the largest market share of approximately 68.0% in 2018, attributed to the properties of the cotton that makes underwear soft, lightweight, and more breathable. Consumers prefer cotton fabric underwear over others for the comfort, high absorbency, and moisture resistance of the fabric. Modal fabric underwear is projected to register the fastest CAGR of 5.6% over the forecasted period. It is a type of rayon and the second generation regenerated cellulosic fiber which is around 50% more absorbent than cotton. It is the softest fabric in men’s underwear segment. Shrink resistance, high wet strength, and absorbent properties of the fabric make it more durable and able to sustain multiple washes and suitable for tumble dry.

Asia Pacific is the largest and fastest growing market for men’s underwear. It is projected to expand at the fastest CAGR of 5.9% over the forecasted period. High demand for underwear owing to high male population in the region can be accredited to the growth. China and India accounted for male population of 714 million and 694 million respectively in 2017. Both these countries together account for more than 70.0% of the regional market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/mens-underwear-market

Further key findings from the report suggest:

Boxer brief type segment held the largest market share of approximately 33.0%% in 2018 and is expected to reach USD 14.23 billion by 2025
Cotton fabric held the largest market share of more than 68.0% in 2018, driven by the properties of cotton that make the underwear soft, lightweight, more breathable, highly absorbent, and moisture resistant
Key players in the men’s underwear market are Phillips-Van Heusen Corporation; Hanesbrands Inc.; Jockey International Inc.; American Eagle Outfitters Inc. and Ralph Lauren Corporation

Baby Car Seat Market Size Worth $10.9 Billion By 2025

The global baby car seat market size is expected to reach USD 10.9 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.4% over the forecast period. Growing awareness regarding child safety, along with the implementation of numerous government regulations in countries including France, Germany, and U.S., is driving the market. For instance, in U.S., there are laws stated by the Insurance Institute of Highway Safety for 50 states, which need to be followed for child safety.

The convertible product segment is expected to expand at the fastest CAGR of 7.1% from 2019 to 2025. It is more economical as compared to other products as it is well suited for both infants and toddlers. It provides both rear and front-facing seats for children.

Europe accounted for the largest share in 2018 and is expected to maintain its lead over the forecast period. Increasing number of government initiatives to use the product for a child of age-group between 0 to 12 years has driven the market. Asia Pacific is expected to be the fastest growing market at a CAGR of 10.4% from 2019 to 2025.

Increasing number of accidents in developing countries such as India and China has led to the rise in installation of the product. However, despite the implementation of various laws, these are not being followed by the national citizens. According to the General Administration of Quality Supervision, Inspection and Quarantine, approximately 18,500 babies die every year due to car accidents in China.

Hypermarkets and supermarkets dominated the industry, accounting for 55.6% share of the overall revenue in 2018. High penetration of these distribution channels in developed economies including U.S. and Germany, along with preference for the technical know-how about the products, has been fueling the growth of this sector.

Key producers of this industry include Dorel Industries Inc.; Goodbaby International Holdings; UPPAbaby; RENOLUX FRANCE INDUSTRY; RECARO Holding GmbH; Newell Brands; Mothercare plc; InfaSecure; Kiwi Baby; and Artsana Group. Product innovation is expected to remain one of the key strategies over the next few years.

For instance, in 2018, Goodbaby International Holdings Limited launched a convertible baby car seat, Cybex Sirona M. This product features sensor safe technology and enables the smart phone connectivity. The smart phone connectivity renders an alert to the driver if the seat is unbuckled during traveling in case of extreme cold or hot temperatures.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/baby-car-seat-market

Further key findings from the study suggest:

By product, the infant segment held the largest share of 32.2% in 2018
Online channel is expected to register the fastest CAGR of 7.1% from 2019 to 2025
Asia Pacific is expected register the fastest CAGR of 10.4% from 2019 to 2025
Europe held the largest share of more than 30.0% in 2018.

Business Software & Services Market Worth $650.13 Billion By 2025

The global business software and services market size is expected to reach USD 650.13 billion by 2025, registering a CAGR of 10.7% from 2019 to 2025, according to a new report by Grand View Research, Inc. Increasing volume of business data and automation of business processes across various industries such as healthcare, retail, and manufacturing are expected to drive the growth.

Numerous factors such as timely product delivery, reduced production costs, and improved operational efficiency delivered by effective business software and services are expected to propel the market growth over the forecast period. Business software and services are extensively used in business processes as they help reduce operational costs.

Enterprises are widely adopting cloud-based deployment solutions owing to technological developments and growing focus on offering flexibility and mobility to users. This is prompting vendors to develop software solutions that can be deployed through cloud platforms.

Technological innovation, growing use of new data sources, and penetration of cloud-based services are further driving the need for customized software solutions for specific business operations. Increasing demand for optimized delivery mechanisms, initiating from point of production to the point of consumption, is encouraging enterprises to adopt supply chain management business software.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/business-software-services-market

Further key findings from the report suggest:

Sales and marketing segment is anticipated to expand at the highest CAGR of 11.2% from 2019 to 2025. The software is widely used by businesses to combine their sales procedures and tasks
Managed services segment is anticipated to register the highest CAGR of 12.2% from 2019 to 2025 owing to the increasing dependence of enterprises on IT assets to improve their productivity
Cloud segment is expected to emerge as the fastest-growing deployment segment over the next six years as this mode of deployment eliminates the need to regularly, manually upgrade business software solutions and enables users to access data from any location in a hassle-free way
Small and Medium Enterprises (SME) segment is expected to expand at the highest CAGR of above 11.2% over the forecast period. The growing number of government initiatives through digital SME campaigns such as video marketing, social media, and search engine marketing are expected to drive the growth
Healthcare is expected to emerge as the fastest-growing end use segment over the next six years, attributed to increasing demand for streamline the documentation, exchange of health data, and its storage
North American accounted for the largest market share in terms of revenue and is expected to continue to dominate the market over the forecast period. Increased adoption of advanced technologies such as hybrid architecture, JavaScript, machine learning, artificial intelligence, and blockchain are contributing significantly to the regional growth
The key players in the business software and services market include Acumatica, Inc.; Deltek, Inc.; Epicor Software Corporation; IBM Corporation; Infor Inc.; NetSuite Inc.; Microsoft Corporation; SAP SE; Oracle Corporation; Totvs SA; Unit4; and SYSPRO

Automotive Electric Fuel Pumps Market Worth $18.44 Billion By 2025

The global automotive electric fuel pumps market size is estimated to reach a value of USD 18.44 billion by 2025, progressing at a CAGR of 5.0% from 2019 to 2025, according to a new study by Grand View Research, Inc. An automotive electric fuel pump is used to pump fuel from tanks to injectors, which further sprays fuel into engine with high pressure. Surging demand for high fuel-efficient pumps to reduce the overall fuel consumption in vehicles along with rise in global vehicle production and sales is anticipated to propel the market over the forecast period.

An electric fuel pump is widely used in vehicles, owing to its numerous benefits such as high product reliability, power output, and fuel efficiency as compared to mechanical fuel pumps. The adoption of automotive electric fuel pumps among original equipment manufacturers (OEMs) in modern vehicles has increased significantly as the product ensures accurate injection pressure and flow of fuel to engine. Moreover, stringent government regulations to produce fuel-efficient and low carbon emission vehicles are expected to create remarkable growth opportunities for the market during the forecast period.

Prominent market players such as Robert Bosch GmbH, Denso Corporation, Delphi Automotive, and Continental AG are increasingly focusing on partnership agreements with automobile manufacturers to supply electric fuel pumps to enhance their overall market presence and profitability. Besides, a few key market players are expanding their production facilities in developing countries to avail the product at affordable costs to OEMs and aftermarket consumers. For instance, in 2013, Continental AG started its new production plants for fuel pumps in India to supply the products to its key clients such as Volkswagen Group.

Despite numerous product benefits, increasing production of counterfeit products, coupled with rapidly growing adoption of electric vehicles, is likely to hinder the growth of the automotive electric fuel pumps market over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/automotive-electric-fuel-pumps-market

Further key findings from the report suggest:

The passenger car segment is poised to dominate the market in terms of revenue throughout the forecast period. Increasing personnel mobility requirements and soaring need for fuel efficient passenger vehicles can contribute to the growth of the segment
Turbine style electric fuel pumps held the leading revenue share in the market in 2018 as they offer higher operational efficiency, lower noise emission, and can deliver accurate pressure measure, driving higher performance of vehicles
Macroeconomic condition and regulation such as mining ban in India may affect the demand of heavy commercial vehicles (HCVs). Increasing demand for LCVs, particularly in rural areas, is anticipated to unfold new growth opportunities for the segment
The Asia Pacific automotive electric fuel pumps market is estimated to experience the highest growth in terms of value during the forecast period. Rising demand for passenger vehicles in developing countries such as India, China, and Korea is escalating the growth of the segment
According to Valeo Group, the number of vehicles produced in China has doubled since 2007, with more than 23 million vehicle productions in 2014, which accounted for 27.0% of the global production
The key industry participants include Denso Corporation, Delphi Automotive PLC, Continental AG, General Motors Company, Pricol Limited, and Robert Bosch. Other prominent vendors include Visteon Corporation, Federal-Mogul Corporation, Daewha Fuel Pump Ind., Ltd., and ACDelco.

Trauma & Extremities Device Market Size Worth $17.9 Billion By 2026

The global trauma and extremities devices market size is expected to reach USD 17.9 billion by 2026, according to a new report by Grand View Research Inc. It is anticipated to expand at a CAGR of 7.7% during the forecast period. Rising geriatric population along with the prevalence of target diseases such as osteoporosis is anticipated to propel the growth. Introduction of new technologies in terms of material and technique and the non-invasive nature of the employed material is augmenting the demand. In July 2016, DePuy Synthes launched a new hand locking system used for deformities and fracture fixation. This device is designed to reduce soft tissue irritation and facilitate healing.

Moreover, companies are investing in new product development, which is anticipated to aid the market growth. In 2015, Smith & Nephew invested USD 222 million on research and development, yielding a promising product pipeline for 2016. It has already launched a new product, SUTUREFIX, a suture anchor in February 2015. The product is expected to improve hip and shoulder repair by providing additional fixation points.

The trauma and extremities device market is led by few players, while local implant manufacturers share the remaining market. DePuy Synthes, Stryker, Zimmer Biomet, and Medtronic and others are key players while Advanced Orthopedic Solutions, Emerge Medical, and Bioretec Ltd. are the emerging players in this vertical.

In 2018, internal fixation led the market owing to the advantages associated with the devices such as sorter hospital stay, lesser scars, and skin pressure, early functionality achieved in patients, and lesser risk of nonunion and malunion of bones. Industry players are adding new products with better functionality, which replicate the native anatomy, enhancing both, functionality and durability. In July 2016, the Acumed’s wrist fixation implants, Acu-Loc and Acu-Loc 2, reached a worldwide sales milestone of 0.5 million in 2 years. This indicates the high demand for internal fixation devices, which is expected to witness growth over the forecasted period.

Amongst internal fixation methods, plates and screws are the most popular owing to the less blood loss involved and shorter operative time. This segment is expected to witness growth owing to the focus of companies on integrating different tools into one system. For instance, in July 2016, DePuy launched its locking hand system comprising 40 basic and specific plates for different cases of hand fractures. This aids the surgeons in adjusting the insertion specific to the patient’s bone anatomy to provide more stability.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/trauma-extremities-market

Further Key Findings from the Report Suggest:

Internal fixation dominated the trauma and extremities device market in 2018 due to the advantages associated with these devices such as lesser scars and reduced hospital stay, and lesser risk of nonunion and malunion of bones
In 2018, North America held the leading market share of more than 45%. The Affordable Care Act includes a separate grant for trauma care. Though this fund was discontinued in 2006, it was reauthorized in 2014 and set to an annual USD 12 million. The fund allocation aimed at improving trauma care centers in terms of access and quality, especially in the rural areas
Some of the key players are DePuy Synthes, Stryker, Zimmer Biomet, Smith & Nephew, Wright Medical Group N.V., Advanced Orthopedic Solutions, Integra Lifesciences, Acumed, Bioretec Ltd., Cardinal Health. They focus on growth strategies such as launch of new products, partnerships, new approval, and mergers & acquisitions

Durable Medical Equipment Market Size Worth $271.0 Billion By 2026

The global durable medical equipment (DME) market size is expected to reach USD 271.0 billion by 2026 registering a CAGR of 6.1%, according to a new report by Grand View Research, Inc. The market is primarily driven by rise in chronic diseases, such as kidney failures and cancer. Moreover, technological advancements along with strong reimbursement scenario will boost the DME market further. For instance, in January 2019, WHILL, Inc., a U.S.-based personal electric vehicle, introduced new technology WHILL autonomous drive at the Consumer Electronic Sow held at the Las Vegas. In the past, Medicare has taken steps to bring reimbursement of DME products in line with other payers.

In this direction, in December 2015, the Center for Medicare & Medicare Services (CMS) issued a new rule of prior authorization process for DME, Prosthetics, Orthotics, and Supplies (DMEPOS). The DMEPOS includes the master list of 135 items, which require prior authorization before beneficiary receives an item. In addition, growing geriatric population across the globe is likely to contribute to the industry expansion. People aged 60 years or above are more prone to health issues, such as diabetes, mobility issues, Cardiovascular Diseases (CVDs), and other lifestyle problems. This creates demand for DME products. However, stringent regulatory guidelines in developed economies and lack of skilled professionals may limit the durable medical equipment market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/durable-medical-equipment-dme-market

Further key findings from the study suggest:

Personal mobility devices emerged as the largest segment owing to the launch of technologically advanced products with more comfort and portability
Nursing homes is anticipated to be the fastest-growing segment over the study period as these facilities offer custodial care like skilled care, such as bathing and dressing
Europe led the market with the largest share in 2018 and will witness a steady growth in future on account of the presence of major companies in the region
Asia Pacific is expected to register the highest CAGR from 2019 to 2026 owing to the presence of a large target population base and improving healthcare facilities
Some of the key companies in the global DME market are Invacare Corporation; ArjoHuntleigh; Stryker Corporation; Hill Rom, Inc.; Drive Medical; GF Health Products, Inc.; Sunrise Medical; Medline Industries, Inc.; and Carex Health Brands, Inc.

Surgical Stapling Devices Market Size Worth $8.02 Billion By 2026

The global surgical stapling devices market size is anticipated to reach USD 8.02 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.23% during the forecast period. Application of surgical staplers has gradually evolved from invasive surgeries to minimally invasive surgeries. With introduction of advanced surgical staplers, difficulties associated with the use of conventional staplers have been addressed.

Obesity is increasing among adults as well as adolescents below 18 years of age due to sedentary lifestyles and unhealthy diet patterns in this age group. In case of eating habits, people are more inclined towards fast food rather than healthy food. Growing busy schedule and increasing stress are both causing people to consume packed and processed food.

Severe cases of obesity cause other conditions, such as diabetes and cardiovascular conditions, resulting in many opting for bariatric surgery. According to the Canadian Institute for Health Information (CIHI) 2014 data, the number of bariatric surgeries has drastically increased from 1,600 in 2006-2007 to 6,000 in 2012-2013. This indicates high demand for these surgeries owing to increasing awareness about surgical options for weight loss.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/surgical-stapling-market

Further key findings from the report suggest:

Manual surgical stapling devices dominated the market in terms of revenue in 2018. However, powered devices are projected to witness strong growth during the forecast period
An alarming number of emergency cases can lead to surgical fatigue, thereby, reducing productivity. Powered stapling devices allow surgeons to perform more number of surgeries in emergency wards
There is an increasing demand for disposable devices due to heightened concerns for communicable infections. Owing to which, disposable staplers are likely to dominate the market through 2025
Disposable staples are made of plastic, whereas reusable staples are made of stainless steel. Both disposable and reusable staples have disposable cartridges and although reusable, staplers generate lesser surgical waste
North America dominated the overall market in terms of revenue in 2018. The growth of the region can be attributed to surging bariatric surgeries, introduction of powered staples, and soaring need for tissue and wound management
Key industry contributors include Covidien plc; Ethicon Endo-Surgery, Inc.; Intuitive Surgical, Inc.; United States Surgical Corp; Cardica, Inc.; Zimmer Holdings, Inc.; Stryker Corporation; Smith & Nephew plc; Conmed Corporation; and CareFusion Corporation
In November 2018, Ethicon launched ECHELON FLEX GST System for exceptional staple line integrity across wide range of tissue thickness under its Bariatric Revision Surgical Solutions.

In vivo CRO Market Size Worth $5.81 Billion By 2026

The global in vivo cro market is anticipated to reach USD 5.81 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand.

In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to rapid growth of generics, patent expirations, and introduction of biosimilar equivalents are encouraging pharmaceutical companies to take the aid of such organizations.

Increasing mergers and collaborations have propelled the value of pharmaceutical outsourcing with major industry contributors expanding into developing regions. The year 2015 experienced high valued transactions as a result of LabCorp acquiring Covance for USD 5.5 billion and the Chinese Private Equity Group acquiring WuXifor USD 3.3 billion. The patent cliff, high research and development cost involved, and globalization in the clinical trial process has driven the

Click the link below:
https://www.grandviewresearch.com/industry-analysis/in-vivo-cro-market

Further key findings from the report suggest:

Rodent based In vivo CRO led the market in 2018 and is anticipated to remain dominant throughout the forecast period. Mice is the most used animal for preclinical evaluation and accounted for almost 76% of the market share in 2018.
Based on indication, oncology held the largest market share in 2018, attributed to the increasing number of cancer cases and focus of pharmaceutical players on introducing novel drug treatments with fewer side-effects
North America led the global In vivo CRO market in 2018 owing to the presence of technologically advanced CROs
Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Constantly improving healthcare infrastructure, huge patient base, presence of untapped opportunities, and economic development, are some factors responsible for the rapid growth
Some of the key market players include Pharmaceutical Product Development, LLC (PPD); IQVIA; American Preclinical Services, LLC.; Charles River Laboratories; Parexel International Corporation; ICON Plc; Covance Inc.; Theorem Clinical research; inVentiv Health; WuXi AppTec, Inc.; American Preclinical Services, LLC.; and Evotec (US), Inc. Partnership and mergers and acquisitions are the key strategic undertakings by these players

Anti-infective Agents Market Worth $144.8 Billion By 2026

The global anti-infective agents market size is expected to reach over USD 144.8 billion by 2026 according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 3.4% during the forecast period. Rising prevalence of infectious diseases such as HIV, H1N1, and Ebola virus reflect the profound changes in behavioral patterns of communities over the recent decades. The societal changes and increasing awareness among healthcare professionals and patients are driving the growth.

Organizations, such as the World Health Organization (WHO) and Centers for Disease control and Prevention (CDC) are actively involved in spreading awareness amongst people regarding the fatal implications of infectious diseases and the importance of early treatment. The CDC has collaborated with the National Health Ministry (NHM) in an attempt to spread awareness and to enhance the treatment of communicable diseases in developing countries such as Brazil, China, Nigeria, and India.

However, introduction of novel therapeutics with increased potency and efficacy and the commercialization of pipeline products, such as commercialization of Omadacycline in 2018 for the treatment of Community Acquired Bacterial Pneumonia (CABP), are expected to propel the growth of the anti-infective agents market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/anti-infective-agents-market

Further key findings from the report suggest:

Antiviral was estimated to be the largest segment with a market share of 48.8% in 2018 owing to the high price associated with the new potent anti-viral drugs, such as Vicriviroc for the treatment of HIV
Antibacterial segment is anticipated to register the fastest CAGR of 4.0% during the forecast period, as antibacterial is the first line of treatment for a large range of infections. Increased prescription and accessibility of antibacterial due to their over-the-counter status is anticipated to further drive the segment
Development of combination drugs to treat and prevent serious and life-threatening infections is expected to propel the usage of anti-infective drugs. For instance, in 2012, Gilead Sciences, Inc. launched Stribild, a comprehensive treatment regimen inclusive of four drugs (cobicistat, elvitegravir, emtricitabine, and tenofovir disoproxil fumarate) used for the treatment of HIV patients without prior retroviral treatment record
Oral route of administration was estimated to be the largest segment in 2018 owing to new product development and presence of strong product pipeline
Hospital pharmacy led the anti-infective agents market in 2018 while e-commerce is expected to be the fastest growing segment during the forecast period
North America was one of the leading regions in terms of revenue in 2018. High prevalence of infectious diseases including hospital-acquired infections in both, children and adults, and the resultant overuse of antibiotics coupled with increased accessibility of non-prescription anti-infectives are the major drivers
Asia Pacific is one of the fastest growing regional segments owing to the presence of high, unmet demand for novel drugs, rapid improvements in healthcare infrastructure coupled with rising awareness among healthcare professionals and patients
Some of the major companies operating in this market are Abbott; Gilead Sciences, Inc.; Bristol-Myers Squibb Company; Merck & Co., Inc.; Bayer AG; AstraZeneca; Boehringer Ingelheim; and Novartis AG.
Effective disease management involves a range of long-term strategies such as new product development, mergers and acquisitions, co-development, and business expansions. For instance, in 2015, ReViral received funding of USD 21 million for the development of its RV521 drug by the Wellcome Trust.